ViaDerma (ViaDerma) Debt-to-Equity : 0.21 (As of Jun. 2012)

View and export this data going back to 2008. Start your Free Trial

What is ViaDerma Debt-to-Equity?

ViaDerma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2012 was $4.42 Mil. ViaDerma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2012 was $2.86 Mil. ViaDerma's Total Stockholders Equity for the quarter that ended in Jun. 2012 was $35.10 Mil. ViaDerma's debt to equity for the quarter that ended in Jun. 2012 was 0.21.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for ViaDerma's Debt-to-Equity or its related term are showing as below:

VDRM's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

ViaDerma Debt-to-Equity Historical Data

The historical data trend for ViaDerma's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma Debt-to-Equity Chart

ViaDerma Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Debt-to-Equity

0.16

0.14

0.17

0.23

ViaDerma Quarterly Data
	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12
Debt-to-Equity	Get a 7-Day Free Trial															0.15	0.26	0.23	0.22	0.21

Competitive Comparison of ViaDerma's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, ViaDerma's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ViaDerma's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ViaDerma's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where ViaDerma's Debt-to-Equity falls into.

ViaDerma Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

ViaDerma's Debt to Equity Ratio for the fiscal year that ended in Dec. 2011 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.356	+	3.32)	/	33.56
	=	0.23

ViaDerma's Debt to Equity Ratio for the quarter that ended in Jun. 2012 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.42	+	2.862)	/	35.098
	=	0.21

ViaDerma (OTCPK:VDRM) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

ViaDerma Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of ViaDerma's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ViaDerma (ViaDerma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292

Website

https://www.viaderma.com

ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.